CareDx Statistics
Total Valuation
CareDx has a market cap or net worth of $3.61 billion. The enterprise value is $3.26 billion.
| Market Cap | 3.61B |
| Enterprise Value | 3.26B |
Important Dates
The next confirmed earnings date is Thursday, October 29, 2026, after market close.
| Earnings Date | Oct 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CareDx has 51.73 million shares outstanding. The number of shares has decreased by -9.45% in one year.
| Current Share Class | 51.73M |
| Shares Outstanding | 51.73M |
| Shares Change (YoY) | -9.45% |
| Shares Change (QoQ) | -3.13% |
| Owned by Insiders (%) | 4.40% |
| Owned by Institutions (%) | 101.57% |
| Float | 49.46M |
Valuation Ratios
The trailing PE ratio is 33.06 and the forward PE ratio is 65.23.
| PE Ratio | 33.06 |
| Forward PE | 65.23 |
| PS Ratio | 7.58 |
| Forward PS | 6.95 |
| PB Ratio | 8.11 |
| P/TBV Ratio | 9.35 |
| P/FCF Ratio | 40.97 |
| P/OCF Ratio | 37.05 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 250.62, with an EV/FCF ratio of 36.79.
| EV / Earnings | 28.07 |
| EV / Sales | 6.80 |
| EV / EBITDA | 250.62 |
| EV / EBIT | n/a |
| EV / FCF | 36.79 |
Financial Position
The company has a current ratio of 4.58, with a Debt / Equity ratio of 0.05.
| Current Ratio | 4.58 |
| Quick Ratio | 4.35 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | 0.97 |
| Debt / FCF | 0.23 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 29.49% and return on invested capital (ROIC) is -1.71%.
| Return on Equity (ROE) | 29.49% |
| Return on Assets (ROA) | -0.25% |
| Return on Invested Capital (ROIC) | -1.71% |
| Return on Capital Employed (ROCE) | -0.45% |
| Weighted Average Cost of Capital (WACC) | 17.26% |
| Revenue Per Employee | $598,809 |
| Profits Per Employee | $145,114 |
| Employee Count | 765 |
| Asset Turnover | 0.94 |
| Inventory Turnover | 7.72 |
Taxes
In the past 12 months, CareDx has paid $4.18 million in taxes.
| Income Tax | 4.18M |
| Effective Tax Rate | 3.63% |
Stock Price Statistics
The stock price has increased by +385.05% in the last 52 weeks. The beta is 2.38, so CareDx's price volatility has been higher than the market average.
| Beta (5Y) | 2.38 |
| 52-Week Price Change | +385.05% |
| 50-Day Moving Average | 55.81 |
| 200-Day Moving Average | 31.51 |
| Relative Strength Index (RSI) | 67.22 |
| Average Volume (20 Days) | 1,536,728 |
Short Selling Information
The latest short interest is 6.59 million, so 12.73% of the outstanding shares have been sold short.
| Short Interest | 6.59M |
| Short Previous Month | 6.30M |
| Short % of Shares Out | 12.73% |
| Short % of Float | 13.32% |
| Short Ratio (days to cover) | 5.19 |
Income Statement
In the last 12 months, CareDx had revenue of $458.09 million and earned $111.01 million in profits. Earnings per share was $2.12.
| Revenue | 458.09M |
| Gross Profit | 323.33M |
| Operating Income | -1.97M |
| Pretax Income | 115.19M |
| Net Income | 111.01M |
| EBITDA | 12.43M |
| EBIT | -1.97M |
| Earnings Per Share (EPS) | $2.12 |
Balance Sheet
The company has $373.64 million in cash and $19.25 million in debt, with a net cash position of $354.39 million or $6.85 per share.
| Cash & Cash Equivalents | 373.64M |
| Total Debt | 19.25M |
| Net Cash | 354.39M |
| Net Cash Per Share | $6.85 |
| Equity (Book Value) | 425.60M |
| Book Value Per Share | 8.27 |
| Working Capital | 335.53M |
Cash Flow
In the last 12 months, operating cash flow was $93.66 million and capital expenditures -$8.95 million, giving a free cash flow of $84.71 million.
| Operating Cash Flow | 93.66M |
| Capital Expenditures | -8.95M |
| Depreciation & Amortization | 14.41M |
| Net Borrowing | n/a |
| Free Cash Flow | 84.71M |
| FCF Per Share | $1.64 |
Margins
Gross margin is 70.58%, with operating and profit margins of -0.43% and 24.23%.
| Gross Margin | 70.58% |
| Operating Margin | -0.43% |
| Pretax Margin | 25.15% |
| Profit Margin | 24.23% |
| EBITDA Margin | 2.71% |
| EBIT Margin | -0.43% |
| FCF Margin | 18.49% |
Dividends & Yields
CareDx does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 9.45% |
| Shareholder Yield | 9.45% |
| Earnings Yield | 3.20% |
| FCF Yield | 2.44% |
Analyst Forecast
The average price target for CareDx is $61.67, which is -11.71% lower than the current price. The consensus rating is "Buy".
| Price Target | $61.67 |
| Price Target Difference | -11.71% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (3Y) | 16.95% |
| EPS Growth Forecast (3Y) | 46.13% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CareDx has an Altman Z-Score of 5.49 and a Piotroski F-Score of 5.
| Altman Z-Score | 5.49 |
| Piotroski F-Score | 5 |